Latest filing published 11 Oct 2024 for GATX CORP, €1.7M.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +26.3%Entry US$135.15 · Close at T+365 US$170.64
- +28.2%Entry US$133.15 · Close at T+365 US$170.64
- -16.5%Entry US$169.25 · Close at T+365 US$141.26
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
State Farm Mutual Automobile Insurance Co: trading record in brief
State Farm Mutual Automobile Insurance Co is a declared insider at 5 companies; the most frequent names are GATX Corp, Yield10 Bioscience, Inc. and Hagerty, Inc. Between 15 November 2006 and 10 October 2024, the trades on record add up to 11 filings.
Every open-market trade on record is a purchase: 7 purchases worth €18.1M, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 2 share grants. 2024 to date brings 6 purchases and no sales.
The median purchase comes to €1.8M. Across 5 purchases, this insider has always bought alone, with no colleague buying within 30 days. For 4 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 75% of cases, with a median move of +11.8%. These figures describe past trades and do not predict future prices.
The latest filing, published on 11 October 2024, reports an open-market purchase of €1.1M in GATX Corp. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to State Farm Mutual Automobile Insurance Co
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 13,840 shares@ US$132.807948.5% of flowCommon StockSEC:0000315032-24-000254:0Canonical exit: 8 Jan 2025 (T+90)
- 8,984 shares@ US$133.6524.0% of flowCommon StockSEC:0000315032-24-000253:1Canonical exit: 7 Jan 2025 (T+90)
- 14,722 shares@ US$133.26951.5% of flowCommon StockSEC:0000315032-24-000253:0Canonical exit: 6 Jan 2025 (T+90)
- 1,800,000 sharesClass A Common StockSEC:0000315032-24-000087:0
- 251,000 shares@ US$19.96100.0% of flowExchange Traded FundSEC:0000315032-24-000086:0Canonical exit: 8 Oct 2024 (T+90)
- 39,641 shares@ US$168.0153100.0% of flowCommon StockSEC:0000315032-23-000024:0Canonical exit: 8 Nov 2023 (T+90)
- 381,335 shares@ US$0.1224Common StockSEC:0000315032-07-000020:0
- 35,795 shares@ US$13.2142Common stockSEC:0000315032-07-000020:1
- 1,769,782 sharesCommon StockSEC:0000315032-06-000023:0
9 of 9 declarations
